Phase I/II clinical trial of Heterologous Human Adult Liver-derived Progenitor Cells (HHALPC, hepastem) in urea cycle disorders (UCD) and Crigler-Najjar syndrome (CN): six months follow-up results
HEPATOLOGY(2014)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要